Sentinel Lymph Nodes in Cutaneous Melanoma.

Area of Science:

• Oncology
• Dermatology
• Surgical Pathology

Background:

• Sentinel lymph node (SLN) examination is the preferred method for early staging in cutaneous melanoma.
• SLNs are the most probable sites for metastatic melanoma deposits.
• SLNs allow for more intensive examination compared to standard lymphadenectomy.

Purpose of the Study:

• To highlight the significance of sentinel lymph node examination in cutaneous melanoma staging.
• To discuss the current protocols and findings in SLN analysis for melanoma.

Main Methods:

• Utilizing formalin-fixed, paraffin-embedded tissue sections.
• Employing hematoxylin and eosin staining.
• Supplementing with immunohistochemistry for enhanced detection.

Main Results:

• Approximately 20% of cutaneous melanoma patients have detectable melanoma cells in their SLNs.
• Detection of positive SLNs is associated with an impaired prognosis.
• Ongoing research explores the therapeutic implications of removing positive SLNs.

Conclusions:

• Sentinel lymph node biopsy is crucial for accurate melanoma staging.
• Positive SLN findings significantly impact patient prognosis.
• Further research is needed to establish therapeutic benefits of SLN removal.